Home/Filings/4/0001214659-21-006371
4//SEC Filing

Snider Lindy 4

Accession 0001214659-21-006371

CIK 0001625288other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 6:00 PM ET

Size

6.0 KB

Accession

0001214659-21-006371

Insider Transaction Report

Form 4
Period: 2021-06-07
Snider Lindy
Director
Transactions
  • Award

    Common stock

    2021-06-07+250,000730,000 total
Holdings
  • Stock option - right to buy

    Exercise: $0.54From: 2018-07-25Exp: 2023-07-25Common stock (100,000 underlying)
    100,000
Footnotes (1)
  • [F1]These shares were issued as compensation for service as a director.

Issuer

NEXIEN BIOPHARMA, INC.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001733367

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 6:00 PM ET
Size
6.0 KB